David M. Polen
Polen Capital Management
Polen Capital Management Portfolio 13F
Polen Capital Management Holdings Activity
- Portfolio value:
- $5.16B≈ (+$35M≈)
- Previous value:
- $5.13B≈
- # of changes:
- 25
- New positions:
- 1
- Reported for:
- 30 Jun 2015 (Q2)
- Latest filing date:
- 13 Aug 2015
Polen Capital Management has disclosed a total of 25 changes to the portfolio in the (2015 Q2) SEC report(s): increased the number of shares of 1, bought 1 totally new, decreased the number of shares of 22 and completely sold out 1 position(s).
In the 2015 Q2 report(s) the following changes have been made to the top investments: (V) Visa Inc, CL-A (reduced shares -2.21%), (NKE) Nike Inc (reduced shares -2.21%), (ABT) Abbott Laboratories (reduced shares -2.18%), (SBUX) Starbucks Corp (reduced shares -4.02%) and (REGN) Regeneron Pharmaceuticals Inc (reduced shares -2.10%).
25 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Meta Platforms Inc
|
new
|
$85.77
|
+580.20%($583.41)
|
3.29%
|
2015 Q2
|
≈ 0.25 years
|
||||
|
|
Baidu Inc
|
+7.19%
|
$199.26
|
-44.12%($111.35)
|
0.00%
|
2015 Q1
|
≈ 0.50 years
|
||||
|
|
Adobe Systems Incorporated
|
-1.18%
|
$81.01
|
+218.76%($258.23)
|
2.12%
|
2015 Q1
|
≈ 0.50 years
|
||||
|
|
Booking Holdings Inc
|
-1.84%
|
$46.05
|
+351.32%($207.86)
|
5.22%
|
2014 Q2
|
≈ 1.25 years
|
||||
|
|
The TJX Companies Inc
|
-2.03%
|
$33.09
|
+381.64%($159.35)
|
5.04%
|
2013 Q4
|
≈ 1.75 years
|
||||
|
|
Fastenal Company
|
-2.06%
|
$10.54
|
+375.91%($50.18)
|
4.08%
|
2013 Q2 or earlier
|
≈ 2.25+ years
|
||||
|
|
Alphabet Inc, CL-C
|
-2.06%
|
$26.03
|
+1,278.22%($358.69)
|
5.05%
|
2014 Q2
|
≈ 1.25 years
|
||||
|
|
Gartner Inc
|
-2.08%
|
$85.78
|
+117.32%($186.42)
|
3.62%
|
2013 Q2 or earlier
|
≈ 2.25+ years
|
||||
|
|
Automatic Data Processing Inc
|
-2.09%
|
$80.23
|
+236.27%($269.79)
|
3.57%
|
2013 Q3
|
≈ 2.00 years
|
||||
|
|
Regeneron Pharmaceuticals Inc
|
-2.10%
|
$510.13
|
+51.14%($771.00)
|
5.48%
|
2013 Q2 or earlier
|
≈ 2.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.